Dr. Jason Kim and Dr. Steven Weissbart at Stony Brook University Hospital have successfully conducted one of the first Glean Urodynamics procedures in the United States using Bright Uro's ambulatory urodynamic system. This marks a significant advancement in evaluating bladder function for the 17 million Americans with daily bladder control issues.
The new technology offers real-time data collection in a natural environment, unlike traditional methods that require catheterization and clinical observation. It provides a more comfortable experience while improving diagnostic accuracy and safety. Patients with lower urinary tract dysfunction can benefit from wireless, catheter-free monitoring of bladder pressure.
Dr. Jason Kim, who is also an associate professor of urology and director of the Women's Pelvic Health and Continence Center at SBUH, served as the national principal investigator for the FDA-approved trial of this system. The trial results were published in the Journal of Endourology.
"We are proud to be at the forefront of urologic innovation," said Dr. Kim. "This new technology marks a major step forward in patient-centered care by providing a more physiologic, less invasive approach to urodynamic testing."
Stony Brook University Hospital is among the first on the East Coast to implement this advanced technology, continuing its leadership in treating pelvic floor disorders and lower urinary tract symptoms.